Date
27 January 2021
With focus on Covid-19, there is little preparedness for next pandemic: Access to Medicine Foundation
Reporting on the 2021 Access to Medicine Index for The Hindu Business Line, PT Jyothi Datta focuses on the spike of research into COVID-19 treatments at the expense of other priority emerging infectious diseases.
The article discusses the lack of access planning in the pipeline of the 20 pharmaceutical companies but points to the collaboration between AstraZeneca and Serum Institute of India for the supply of the COVID-19 vaccine. It also underlines the significance of IP sharing in broadening access.
The article concludes with an overview of the top ranking companies.
Read the full article here.